The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Boehringer Ingelheim; MSD
Travel, Accommodations, Expenses - Roche Pharma AG
Final results of a phase II study of oral vinorelbine (NVBo) monotherapy in patients (pts) with advanced EGFR-positive non-small-cell lung cancer (NSCLC) after failure of EGFR-TKI in first line (NAVoTRIAL 2).
 
Eng-Huat Tan
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis
Speakers' Bureau - Boehringer Ingelheim; Novartis
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Pierre Fabre
 
Giuseppe Luigi Banna
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Italfarmaco
 
Rodryg Ramlau
No Relationships to Disclose
 
Giovanni Luca Ceresoli
No Relationships to Disclose
 
Andrea Camerini
Consulting or Advisory Role - AstraZeneca; Pfizer; Pierre Fabre; Roche
 
Janusz Milanowski
No Relationships to Disclose
 
Michele Caruso
No Relationships to Disclose
 
Philippe Landreau
No Relationships to Disclose
 
Marcello Riggi
No Relationships to Disclose
 
Dariusz Kowalski
No Relationships to Disclose